Atlas Trials

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

Clinical trial NCT04729543 · RECRUITING

Trial details

NCT number
NCT04729543
Sponsor
Erasmus Medical Center
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MelanomaMelanoma, UvealHead and Neck Cancer
Start date
2020-10-20
Primary completion
2024-12-20
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.